Healthtech Startups

A consortium and organization working to accelerate the development of therapeutics, vaccines, and products to combat antimicrobial resistance (AMR) through multiple innovation platforms. The organization supports industry partners, particularly early-stage biotech startups, in advancing solutions to address this global health crisis.

1 investor

Infinite Athlete operates as a parent company combining sports video and data technology with biomechanical analytics and performance engineering. The company serves athletes, sports organizations, broadcasters, and fans through a portfolio that includes Tempus Ex Machina (live event data and video sync platform) and Biocore (health, safety, and injury prevention analytics).

1 investor

Infius Health manufactures in-vitro diagnostic kits that automate manual medical testing procedures. The company serves healthcare providers and laboratories requiring diagnostic solutions.

1 investor

InformedDNA applies genetics expertise and technology to deliver genomics insights and services such as telegenetic counseling for payors, healthcare providers, and patients across the US. It operates in the digital health and genomics space, supporting clinical decisions around screening, diagnosis, and treatment.

1 investor

Informuta provides predictive infection intelligence tools that forecast antibiotic resistance risk to help clinicians prevent treatment failures and optimize antibiotic prescribing decisions. The company serves healthcare providers and infectious disease practitioners with AI-driven diagnostics and bacterial evolutionary analytics.

1 investor

Infraredx develops intravascular imaging technology that combines high-resolution structural imaging with plaque compositional analysis to inform vascular treatment decisions. The company operates in the medical device sector and is a U.S. subsidiary within Nipro Corporation's Vascular Division.

1 investor

InfuCare Rx provides specialized infusion therapies and medications, supported by an interdisciplinary team of healthcare professionals. The company offers personalized therapy programs and patient education to improve health outcomes.

1 investor

In Full Health is a community and initiative focused on advancing equitable opportunities in health innovation investment, solution development, and purchasing across the U.S. It promotes prioritizing investment in health innovations developed by, with, and for historically marginalized communities.

1 investor

Infusion Innovations develops medical devices and intelligent systems for home infusion therapies, serving healthcare providers in Australia/New Zealand, North America, and Europe. The company addresses complex health conditions including rheumatology, gastrointestinal disorders, infectious diseases, cancer, and immune deficiencies through condition-specific technologies, clinical management tools, and data analytics.

1 investor

Infusive provides a unified software platform designed to manage the back office operations of wellness practices, replacing spreadsheets and fragmented systems.

1 investor

Ingenovis Health operates an ecosystem of specialized staffing brands that place travel, rapid response, and specialty clinicians with hospitals, health systems, and healthcare facilities across the United States. It provides workforce solutions and talent operations for healthcare organizations and career pathways and support resources for clinicians.

1 investor

Ingenum is a veterinary data science company that applies artificial intelligence and epidemiological expertise to surveillance and disease detection in agriculture and biosecurity. The company serves agricultural businesses and biosecurity organizations in New Zealand.

1 investor

InHandPlus develops a wrist-worn camera and IMU device embedded in a watch to capture hand and activity data. The company operates two businesses: a healthcare platform deployed with Korean hospitals and welfare centers, and licensed physical AI datasets for robotics teams training dexterous hand manipulation.

1 investor

RDi Evolve (formerly Inicio) develops digital healthcare solutions including AI/ML for clinical applications, intelligent automation, and diagnostics tools designed for healthcare systems and providers. The company specializes in interoperability platforms, EHR enhancements, and automation to improve clinical workflows and patient outcomes.

1 investor

Inimmune is a clinical-stage biotech company developing immunotherapies for allergy, cancer, infectious, and autoimmune diseases. The company combines immunology and vaccine expertise to advance its clinical and pre-clinical pipeline.

1 investor

1 investor

INJU is a German food technology company that produces liquid nutritional supplements containing vitamins, minerals, and plant-derived compounds. The company manufactures all products in-house in Berlin and targets consumers seeking daily nutritional support.

1 investor

INKE develops and manufactures active pharmaceutical ingredients (APIs), including high-potency APIs and ophthalmic solutions, using chemical synthesis and micronization technologies. It operates two cGMP manufacturing sites with capabilities in crystal engineering, chromatographic purification, and high-containment handling.

1 investor

Inmar builds data-driven technology solutions for brands, retailers, and healthcare companies, spanning AI-powered analytics, digital promotions and shopper loyalty, and prescription return programs. Its offerings connect commerce and healthcare ecosystems to support growth, regulatory compliance, and patient safety.

1 investor

Inmedix develops the CloudHRV System, an FDA-cleared clinical diagnostic that performs a 5-minute heart rate variability analysis of both the sympathetic and parasympathetic branches of the autonomic nervous system. The medical-grade test is used in clinical settings and covered by most insurance, with sites operating in Washington, Oregon, Michigan and Florida.

1 investor

Corpus VR develops CE- and FDA-registered virtual reality therapy software with 40+ exercise environments for physical, mental, and neurological rehabilitation. It is used by physiotherapists, occupational therapists, rehabilitation specialists, hospitals, clinics, and corporate wellness programs to improve therapy adherence and recovery.

1 investor

The Laboratory of Immuno-Regulation (LIR) is a research group at the Gregorio Marañón Hospital Health Research Institute in Madrid that studies regulatory T cells and thymic tissue for treating autoimmune diseases and transplant rejection. Its work includes cell-based therapies and has led to a biotech spin-off, Thytech.

1 investor

InnAccel Technologies develops advanced medical devices and intelligent healthcare solutions using a structured biodesign methodology to address clinical unmet needs in critical care and maternal health settings.

1 investor

InnAVasc develops a vascular access graft for hemodialysis, featuring self-sealing pods and puncture-resistant backplates that guide dialysis needle placement to reduce needle-injury and bleeding complications. The product targets patients requiring hemodialysis access.

1 investor